DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slid 1.19% to $542.50 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 4.36% to 7,353.73 and Dow Jones Industrial Average falling 3.44% to 51,523.06.
Vertex Pharmaceuticals Inc. closed 4.60% short of its 52-week high of $568.67, which the company reached on November 2nd.
Despite its losses, the stock outperformed some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 2.24% to $288.24, Krystal Biotech Inc. (KRYS) fell 3.41% to $300.25, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 13.89% to $9.36.
Trading volume (2.4 M) eclipsed its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 5, 2026.
Comments